Alkem Laboratories: Singh acquires shares; Adroit Biomed acquisition finalized
Alkem Laboratories has seen significant activity with the substantial acquisition of shares by Mrs. Madhurima Singh and the finalization of the Adroit Biomed Limited acquisition. On March 25, 2025, Mrs. Singh acquired 1,663,145 equity shares, increasing her stake in the company from 4.79% to 6.18%. This acquisition was made pursuant to the transmission of shares from the estate of the late Mr. Dhananjay Kumar Singh. Concurrently, on March 28, 2025, Alkem Laboratories announced the execution of a Share Purchase Agreement, formalizing the acquisition of 100% stake in Adroit Biomed Limited, first disclosed on February 7, 2025. The company has made available this announcement on its website to comply with SEBI regulations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Alkem Laboratories publishes news
Free account required • Unsubscribe anytime